SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant
þ
Filed by a Party other than the Registrant o
Check the appropriate box:
þ | Preliminary Proxy Statement |
o | Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
o | Definitive Proxy Statement |
o | Definitive Additional Materials |
o | Soliciting Material Pursuant to Rule 14a-12 |
BEVERLY ENTERPRISES, INC.
Payment of Filing Fee (Check the appropriate box):
þ | No fee required. |
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which transaction applies: |
|||
(2) | Aggregate number of securities to which transaction applies: |
|||
(3) | Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined): |
|||
(4) | Proposed maximum aggregate value of transaction: |
|||
(5) | Total fee paid: |
o | Fee paid previously with preliminary materials. | |||
o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: |
|||
(2) | Form, Schedule or Registration Statement No.: |
|||
(3) | Filing Party: |
|||
(4) | Date Filed: |
| A group including Arnold Whitman, the Chief Executive Officer of Formation Capital, LLC and Appaloosa Management L.P., a New Jersey based hedge fund, among others, is attempting to take control of your companys Board at the meeting as part of its efforts to acquire BEI. | |
| As described in the accompanying Proxy Statement, your Boards unanimous view is that the transactions proposed by this group are not in the best interests of BEI stockholders and significantly undervalue BEI. |
| FOR the BEI nominees for director; and | |
| AGAINST the Whitman/Appaloosa group proposals under Items 3-5 on the enclosed WHITE proxy card. |
Sincerely, | |
William R. Floyd | |
Chairman, President and | |
Chief Executive Officer |
TIME AND DATE | 10:00 a.m., CDT, on Thursday, April 21, 2005 | |
PLACE |
Beverly Enterprises, Inc. One Thousand Beverly Way Fort Smith, Arkansas 72919 |
|
ITEMS OF BUSINESS | (1) Election of eight directors. YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR ELECTION OF THE EIGHT BEI DIRECTOR NOMINEES (Item 1 on the enclosed WHITE proxy card). | |
(2) Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2005. YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR THIS PROPOSAL (Item 2 on the enclosed WHITE proxy card); and | ||
(3) Transaction of any other business properly brought before the Annual Meeting, including at any adjournment or postponement of the Annual Meeting. | ||
RECORD DATE | If you were a stockholder as of the close of business on March 7, 2005 (the Record Date), you are entitled to vote and attend the Annual Meeting. | |
ANNUAL REPORT | We will furnish a copy of our annual report containing our audited consolidated financial statements for the year ended December 31, 2004 to BEI stockholders as promptly as practicable on or after March 15, 2005 and in no event later than April 1, 2005, a date 20 calendar days before the date of the 2005 annual meeting. | |
PROXY VOTING | It is important that your shares of stock be represented and voted at the meeting. Please SIGN, DATE AND PROMPTLY RETURN the enclosed WHITE proxy card in the postage-paid envelope. | |
Any proxy may be revoked at any time prior to its exercise at the meeting by following the instructions in the Proxy Statement. | ||
March 15, 2005 |
DOUGLAS J. BABB Secretary |
|
Page | |||||
1 | |||||
10 | |||||
14 | |||||
16 | |||||
Proposal
No. 1
Election of Directors
|
16 | ||||
Proposal
No. 2
Ratification of the
Appointment of Ernst & Young LLP as Our Independent
Registered Public accounting Firm for 2005
|
16 | ||||
18 | |||||
Board
of Directors
Committees During 2004
|
20 | ||||
Board
of Directors
Compensation
|
23 | ||||
24 | |||||
26 | |||||
28 | |||||
30 | |||||
35 | |||||
35 | |||||
39 | |||||
Long-Term
Incentive Plans
Awards in Last Fiscal
Year
|
39 | ||||
40 | |||||
41 | |||||
42 | |||||
42 | |||||
Section
16(a) Beneficial
Ownership Reporting Compliance
|
43 | ||||
43 | |||||
43 | |||||
45 | |||||
I-1 | |||||
II-1 |
i
1. Q. | Why am I receiving these proxy materials? | |
A. | BEIs Board of Directors is asking for the right to vote your shares as your proxy or agent at the Annual Meeting. Acting as your proxy, a member of the Proxy Committee, appointed by the Board, will vote your shares as you instruct on your proxy card. This Proxy Statement discusses the issues to be voted on. Each share you own is entitled to one vote on each matter considered at the Annual Meeting. | |
2. Q. | On which proposals may I vote? | |
A. | You will be voting on: | |
(1) Election of eight directors; | ||
(2) Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2005; and | ||
(3) Approval or disapproval of any other business properly presented for a vote at the Annual Meeting. Please see Question and Answer 5 and Question and Answer 6 below. | ||
3. Q. | Who is being nominated for election as a director? | |
A. | Your Board has nominated William R. Floyd, Melanie Creagan Dreher, Ph.D., John D. Fowler, Jr., John P. Howe, III, M.D., James W. McLane, Ivan R. Sabel, Donald L. Seeley and Marilyn R. Seymann, Ph.D., for election as directors at the Annual Meeting. Additional information about each of the BEI nominees is included under the heading BEI Nominees for the Board of Directors below. | |
As you may know, a group including Arnold Whitman, the Chief Executive Officer of Formation Capital, LLC and Appaloosa Management L.P., a New Jersey based hedge fund, among others, has acquired over eight percent of our outstanding stock and has sent us two letters proposing an acquisition of BEI. This group, through Mr. Whitman, has nominated six individuals for election as directors of BEI at the Annual Meeting in order to take control of the Board and further their attempt to acquire BEI. | ||
Your Board has unanimously determined that the transactions proposed by the Whitman/Appaloosa group significantly undervalue BEI and are not in the best interests of BEI or its stockholders. | ||
YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR ELECTION OF THE EIGHT BEI DIRECTOR NOMINEES (ITEM 1 ON THE ENCLOSED WHITE PROXY CARD). | ||
We urge you NOT to sign or return any blue proxy card sent to you by the Whitman/Appaloosa group for any reason, which would void any earlier-dated proxy. The best way to support your Board is by voting: | ||
FOR BEIs nominees for director; and | ||
AGAINST Items 3-5 on the enclosed WHITE proxy card (the Whitman/Appaloosa group proposals). |
4. Q. | What vote is required to elect directors? | |
A. | With respect to the election of directors, you may: | |
Vote for the election of any or all of the eight BEI director nominees; or | ||
Withhold authority to vote for any or all of the eight BEI director nominees. | ||
You may take any of these actions by marking the appropriate spaces on the enclosed WHITE proxy card. If you submit your signed WHITE proxy card without indicating how you wish to vote, your shares will be voted FOR the election of the BEI director nominees. | ||
If you receive a proxy statement from the Whitman/Appaloosa group or attend the Annual Meeting, you may also be able to vote on their nominees for election as directors at the Annual Meeting. | ||
BEIs By-Laws provide that directors will be elected by a plurality of votes cast, in person or by proxy, and entitled to vote at the Annual Meeting at which a quorum is present. Stockholders do not have the right to cumulate votes in the election of directors. Accordingly, the eight nominees receiving the highest vote totals will be elected as directors of BEI. Votes that are withheld in the election of directors and broker non-votes will not be taken into account for purposes of determining the outcome of the election. | ||
The only way to vote by proxy FOR the BEI nominees is to sign, date and return the enclosed WHITE proxy card. Do NOT sign or return any blue proxy card sent to you by the Whitman/Appaloosa group for any reason, even as a protest against their activities. The best way to support your Board is by voting: | ||
FOR BEIs nominees for director; and | ||
AGAINST Items 3-5 on the enclosed WHITE proxy card (the Whitman/Appaloosa group proposals). | ||
YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR ELECTION OF THE EIGHT BEI DIRECTOR NOMINEES (ITEM 1 ON THE ENCLOSED WHITE PROXY CARD). | ||
5. Q. | What business other than the election of directors will be conducted at the Annual Meeting? | |
A. | BEI has set forth Proposal No. 2, which asks the stockholders to ratify the appointment of Ernst & Young LLP as BEIs independent registered public accounting firm for 2005. | |
YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR THIS PROPOSAL (ITEM 2 ON THE ENCLOSED WHITE PROXY CARD). | ||
We also have received notice from Arnold M. Whitman, the Chief Executive Officer of Formation Capital, that he intends to bring the following proposals before the Annual Meeting for consideration by BEIs stockholders: | ||
A proposal to amend our By-Laws to fix the number of directors constituting the entire Board at eight (Item 3 on the enclosed WHITE proxy card); | ||
A proposal to repeal any amendment to our By-Laws adopted after May 29, 1997, other than the proposed amendment described above (Item 4 on the enclosed WHITE proxy card); and | ||
A proposal to require that the foregoing proposals be presented prior to the election of directors and before any other business is conducted at the Annual Meeting (Item 5 on the enclosed WHITE proxy card). | ||
YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE AGAINST EACH OF THESE PROPOSALS SUBMITTED BY THE WHITMAN/APPALOOSA GROUP (ITEMS 3-5 ON THE ENCLOSED WHITE PROXY CARD). More information regarding these |
2
proposals, and the reasons for your Boards recommendation, may be found under the heading Other Matters below. | ||
6. Q. | What vote is required for the other proposals that may be considered at the Annual Meeting? | |
A. | The affirmative vote of the holders of a majority of the shares present, in person or by proxy, and entitled to vote on this proposal at the Annual Meeting at which a quorum is present is required for stockholder ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2005. | |
You may vote for or against this proposal or abstain from voting. Abstentions will have the same effect as if you voted against this proposal. If this proposal is contested, broker non-votes will not affect the outcome of the vote on this matter. | ||
If you submit your signed WHITE proxy card and either vote for this proposal or do not indicate a vote, you will be voting for the proposal. If you submit your signed WHITE proxy card and either vote against this proposal or abstain from voting, then you will be voting against the proposal. | ||
YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR THE PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP (ITEM 2 ON THE ENCLOSED WHITE PROXY CARD). | ||
Under BEIs By-Laws, the affirmative vote of the holders of a majority of the outstanding shares of BEI common stock is required to amend or repeal the By-Laws. As a result, the affirmative vote of the holders of a majority of the outstanding shares of BEI common stock is required to amend our By-Laws to fix the number of directors constituting the entire Board at eight or to repeal any amendment to our By-Laws adopted after May 29, 1997. In addition, the affirmative vote of the holders of a majority of the shares present, in person or by proxy, and entitled to vote on the matter at the Annual Meeting at which a quorum is present is required to approve the proposal to conduct business in the order proposed by the Whitman/ Appaloosa group. | ||
You may vote for or against each of these matters or abstain from voting with respect to each of these matters. Abstentions with respect to any of these proposals will have the same effect as a vote against such proposals. Broker non-votes will have the same effect as a vote against the proposals to amend our By-Laws. Broker non-votes will not affect the outcome of the vote with respect to the proposal to conduct business in the order proposed by the Whitman/ Appaloosa group. | ||
If you submit your signed WHITE proxy card and vote for any of the Whitman/ Appaloosa group proposals, you will be voting for such proposal. If you submit your signed WHITE proxy card and either vote against any of the Whitman/ Appaloosa group proposals, abstain from voting or do not indicate a vote, then you will be voting against such proposals. | ||
YOUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE AGAINST EACH OF ITEMS 3-5 ON THE ENCLOSED WHITE PROXY CARD. | ||
7. Q. | How does our Board recommend I vote on the enclosed WHITE proxy card? | |
A. | Your Board unanimously recommends you vote: | |
FOR each BEI director nominee (Item 1 on the enclosed WHITE proxy card); and | ||
FOR ratification of the appointment of Ernst & Young LLP as BEIs independent registered public accounting firm for 2005 (Item 2 on the enclosed WHITE proxy card). | ||
We have not made any changes to our By-Laws since May 19, 1997. Your Board unanimously recommends you vote AGAINST the proposals to amend our By-Laws to fix the number of directors constituting the entire Board at eight, to repeal any amendment to our By-Laws adopted after May 29, 1997 and to conduct business in the order proposed by the Whitman/ Appaloosa group (Items 3-5 on the enclosed WHITE proxy card). |
3
8. Q. | Who is entitled to vote? | |
A. | Stockholders as of the close of business on March 7, 2005 (the Record Date) are entitled to vote at the Annual Meeting. As required by Delaware law, a list of stockholders entitled to vote at the Annual Meeting will be available at the Annual Meeting on April 21, 2005 and for 10 days prior to the meeting, during normal business hours, at BEIs corporate office located at One Thousand Beverly Way, Fort Smith, Arkansas 72919. | |
9. Q. | Does holding my stock in a brokerage account affect my entitlement to vote? | |
A. | If your shares are held in the name of a broker, only your broker can execute a proxy and vote your shares. Please sign, date and promptly mail the WHITE voting instruction card in the envelope provided by your broker. Remember, your shares cannot be voted (except with respect to the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm, so long as such proposal is not contested at the time of the Annual Meeting) unless you return a signed and dated voting instruction card to your broker or attend the Annual Meeting to vote your shares in person. If your shares are held in the name of a broker, and you intend to attend the Annual Meeting and vote your shares in person, you must obtain a legal proxy, executed in your favor, from your broker to be able to vote at the Annual Meeting. However, you should still sign, date and promptly mail the WHITE voting instruction card in the envelope provided by your broker to preserve your right to vote. If you attend the Annual Meeting and vote, your proxy will be revoked. | |
10. Q. | What happens if I dont instruct my broker how to vote? | |
A. | If you dont return a voting instruction card, your broker will not be able to vote on Items 1, 3, 4 and 5. Your broker will be able to vote with respect to Item 2 only if that proposal is not contested at the time of the Annual Meeting. Therefore, if you do not return a voting instruction card: | |
your vote will not be taken into account for purposes of determining the outcome of the election of directors; | ||
your broker will have discretion to vote with respect to the ratification of the appointment of Ernst & Young LLP, assuming the ratification is uncontested; | ||
your vote will not be taken into account with respect to the proposals to amend our By-Laws, which will have the same effect as a vote against the proposals; and | ||
your vote will not be taken into account for purposes of determining the outcome of the proposal to conduct business in the order proposed by the Whitman/ Appaloosa group. | ||
11. Q. | What happens if I do not vote the shares registered in my name? | |
A. | If your shares are held in a registered account maintained by the transfer agent, The Bank of New York, your shares will not be voted or considered in the determination of a quorum unless you submit a proxy card or vote at the Annual Meeting. | |
12. Q. | What is a quorum? | |
A. | A quorum is a majority of BEIs issued and outstanding shares of common stock and is required to hold the Annual Meeting. As of the Record Date, there were 108,787,095 shares of BEI common stock issued and outstanding, all of one class and each having one vote. There must be at least 54,393,548 shares present or represented by proxy at the Annual Meeting for business to be transacted. If you send the enclosed WHITE proxy card to BEI, your shares will be considered part of the quorum, regardless of how you vote. |
4
13. Q. | How do I vote? | |
A. | Your vote is important. You may vote by mail or by attending the Annual Meeting and voting by ballot, all as described below. | |
Vote by Mail | ||
If you choose to vote by mail, simply date and sign your WHITE proxy card or voting instruction card and return it in the postage-paid envelope provided. If the envelope is missing, please mail your completed WHITE proxy card to Innisfree M&A Incorporated, P.O. Box 5154, FDR Station, New York, NY 10150-5154, or your completed voting instruction card to your broker, bank or nominee. | ||
If you return your signed WHITE proxy card, but do not mark the boxes showing how you wish to vote, your shares will be voted by a member of BEIs Proxy Committee in accordance with your Boards recommendations described in this Proxy Statement. The members of the Proxy Committee are Douglas J. Babb, William R. Floyd and Jeffrey P. Freimark. | ||
Voting at the Annual Meeting | ||
The method or timing of your vote will not limit your right to vote at the Annual Meeting if you attend the meeting and vote in person. However, if your shares are held in the name of a broker, you must obtain a legal proxy, executed in your favor, from your broker to be able to vote at the Annual Meeting. You should allow yourself enough time prior to the Annual Meeting to obtain this proxy from the holder of record. | ||
The shares represented by the proxy cards received, properly marked, dated, signed and not revoked will be voted at the Annual Meeting. | ||
14. Q. | Can I revoke or change my vote after I return a proxy card? | |
A. | You can revoke any proxy you give at any time before your shares are voted. You can revoke a proxy in any one of three ways: | |
submit a valid, later-dated proxy card; | ||
notify BEIs Corporate Secretary in writing at One Thousand Beverly Way, Fort Smith, Arkansas 72919, before the Annual Meeting that you have revoked your proxy; or | ||
vote in person at the Annual Meeting. | ||
Attendance at the meeting in itself will not constitute revocation of a proxy. | ||
If you have returned a blue proxy card to the Whitman/Appaloosa group, we urge you to revoke your proxy by signing, dating and returning the enclosed WHITE proxy card to BEI. | ||
15. Q. | What does it mean if I get more than one WHITE proxy card? | |
A. | If your shares are registered differently and are in more than one account, you will receive more than one WHITE proxy card. PLEASE SIGN AND RETURN ALL WHITE PROXY CARDS TO ENSURE THAT ALL OF YOUR SHARES ARE VOTED. | |
16. Q. | Who will count the votes? | |
A. | Representatives of IVS Associates, Inc., an independent tabulator appointed by the Board of Directors, will count the votes and act as inspectors of election. The inspectors of election shall have the authority to receive, inspect, electronically tally and determine the validity of proxies received. | |
17. Q. | How will voting on any other business be conducted? | |
A. | Other than those items described in this Proxy Statement, we do not know of any business to be conducted at the Annual Meeting. However, if any other business is properly presented, your signed WHITE proxy card gives authority to each member of the Proxy Committee to vote or refrain from voting on such matters at his discretion. |
5
18. Q. | How do I vote if I participate in the Employee Stock Purchase Plan or the Beverly Enterprises, Inc. 401(k) SavingsPlus Plan? | |
A. | Computershare, as administrator of the Employee Stock Purchase Plan, is the record holder of the shares held in BEIs Employee Stock Purchase Plan. If you are a participant in the Employee Stock Purchase Plan, your shares are held in a nominee position with Computershares broker dealer, Merrill Lynch. Computershare will seek instructions from you on how to vote and convey those instructions to Merrill Lynch, who in turn will vote your shares. | |
Similarly, Diversified Investment Advisors, as recordkeeper of the Beverly Enterprises, Inc. 401(k) SavingsPlus Plan, is the record holder of the shares held in the plan. If you are a participant in the Beverly Enterprises, Inc. 401(k) SavingsPlus Plan, your shares are held in a nominee position with Investors Bank and Trust, the 401(k) Plan trustee. Diversified Investment Advisors will seek instructions from you on how to vote and convey those instructions to Investors Bank and Trust, who in turn will vote your shares. | ||
19. Q. | Who can attend the Annual Meeting? | |
A. | Admission to the Annual Meeting is limited to stockholders of BEI, persons holding validly executed proxies from stockholders who held BEI common stock at the close of business on March 7, 2005, and invited guests of BEI. | |
If you are a stockholder of BEI, you must bring certain documents with you in order to be admitted to the Annual Meeting. The purpose of this requirement is to help us verify that you are actually a stockholder of BEI. Please read the following rules carefully, because they specify the documents that you must bring with you to the Annual Meeting in order to be admitted. The items that you must bring with you differ depending upon whether you are a record holder or hold your stock in street name. | ||
Proof of ownership of BEI common stock must be shown at the door. Failure to provide adequate proof that you were a stockholder on the record date may prevent you from being admitted to the Annual Meeting. | ||
If you were a record holder of BEI common stock on March 7, 2005, then you must bring a valid government-issued personal identification (such as a drivers license or passport). | ||
If a broker was the record holder of your shares of BEI common stock on March 7, 2005, then you must bring: | ||
Valid government-issued personal identification (such as a drivers license or passport); and | ||
Proof that you beneficially owned shares of BEI common stock at the close of business on March 7, 2005. | ||
Examples of proof of beneficial ownership include the following (1) a letter from your bank or broker stating that you owned BEI common stock on March 7, 2005; (2) a brokerage statement indicating that you owned BEI common stock on March 7, 2005; or (3) a copy of the voting instruction card provided by your broker indicating that you owned BEI common stock on March 7, 2005. | ||
If you are a proxy holder for a stockholder of BEI, then you must bring: | ||
The validly executed proxy naming you as the proxy holder, signed by a stockholder of BEI who owned shares of BEI common stock on March 7, 2005; | ||
Valid government-issued personal identification (such as a drivers license or passport); and | ||
If the stockholder whose proxy you hold was not a record holder of BEI common stock on March 7, 2005, proof of the stockholders beneficial ownership of shares of BEI common stock on March 7, 2005, in the form of a letter or statement from a broker or the voting instruction card provided by the broker, in each case indicating that the stockholder owned BEI common stock on March 7, 2005. |
6
You may not use cameras, recording equipment or other electronic devices during the Annual Meeting. | ||
20. Q. | When are the stockholder proposals for the 2006 Annual Meeting due? | |
A. | All stockholder proposals to be considered for inclusion in next years proxy statement must be submitted in writing for receipt by November 15, 2005. They should be sent to the Corporate Secretary, Beverly Enterprises, Inc., One Thousand Beverly Way, Fort Smith, AR 72919. | |
Additionally, BEIs advance notice by-law provision requires that any stockholder proposal to be presented from the floor of the 2006 Annual Meeting be received by the Corporate Secretary at least seventy-five (75) days before the meeting. It is currently expected that the 2006 Annual Meeting will be held on April 20, 2006. If this is the date set by the Board, stockholder proposals to be presented from the floor will be due by February 4, 2006. Proposals may be presented from the floor only after a determination has been made that it is a proper matter for consideration. | ||
21. Q. | Can a stockholder recommend someone to be a nominee for election as a director at the 2006 Annual Meeting? | |
A. | As a stockholder, you may recommend any person to be a nominee for director by writing to the Chairman of the Nominating and Compensation Committee of the Board, c/o the Corporate Secretary at BEIs address above. The recommendations must be received by BEI no later than the date by which stockholder proposals must be received to be considered for inclusion in the proxy statement, which is the first date set forth in Question and Answer 20 above. Each recommendation must be accompanied in writing by the following information: | |
name and address of the stockholder recommending the nomination; | ||
a representation that the stockholder recommending the nomination is a record holder; | ||
a representation that the stockholder recommending the nomination intends to appear in person or by proxy at the Annual Meeting to nominate the person or persons specified; | ||
information regarding each recommended potential director nominee that would be required to be included in a proxy statement; | ||
a description of any arrangements or understandings between the stockholder recommending the nomination and the recommended potential director nominee; and | ||
the consent of each recommended potential director nominee to serve as a director, if elected. | ||
22. Q. | Are there any specific, minimum qualifications for director nominees? | |
A. | The Nominating and Compensation Committee of the Board has established certain criteria it considers as a guideline in considering nominations to BEIs Board of Directors. The criteria include: character, knowledge, experience, education, business judgment, diligence, stock ownership, independence, loyalty, reputation and ability to contribute to board balance and diversity. These criteria are not exhaustive, and the Nominating and Compensation Committee and the Board of Directors may consider other qualifications and attributes which they believe are appropriate in evaluating the ability of an individual to serve as a member of the Board of Directors. | |
23. Q. | What is the Nominating and Compensation Committees process of identifying and evaluating nominees? | |
A. | Prior to each Annual Meeting of stockholders at which directors are to be elected, and whenever there is otherwise a vacancy on the Board of Directors, the Nominating and Compensation Committee will consider incumbent Board members and other well-qualified individuals as potential director nominees. The Nominating and Compensation Committee will determine whether to retain an executive search firm to identify Board candidates. If an executive search firm is retained, the Nominating and Compensation Committee will select the search firm, approve the search firms fees |
7
and other retention terms and specify for the search firm the criteria to use in identifying potential candidates consistent with the director qualification criteria described above. The Nominating and Compensation Committee will review each potential candidate. Management may assist the Nominating and Compensation Committee in the review process at the Committees direction. The Nominating and Compensation Committee will select the candidate or candidates it believes are the most qualified to recommend to the Board for selection as a director nominee. Candidates recommended by a security holder will be evaluated in the same manner as candidates identified by the Nominating and Compensation Committee. | ||
With the exception of Melanie Creagan Dreher, Ph.D., each of the nominees for election as a director at the 2005 Annual Meeting was elected at the Annual Meeting of stockholders held in 2004. Dr. Dreher was initially identified as a potential candidate by a professional search firm. The qualifications of Dr. Dreher were then reviewed by the members of the Nominating and Compensation Committee. All of the BEI nominees are recommended by the Nominating and Compensation Committee to stand for election by the stockholders. | ||
24. Q. | Who is soliciting my proxy? | |
A. | Under applicable regulations of the SEC, each of our directors, certain officers of BEI and certain other persons may be deemed to be participants in BEIs solicitations of proxies in connection with the Annual Meeting. For information with respect to each participant in BEIs solicitation of proxies in connection with the Annual Meeting, please refer to (i) the table of security ownership of directors and executive officers under the heading Security Ownership of Certain Beneficial Owners and Management, (ii) the discussion under the headings Executive Compensation and Employment Contracts, Termination of Employment and Change in Control Agreements, and (iii) Schedules I and II to this Proxy Statement. | |
For additional information regarding BEIs solicitation of proxies, please see Solicitation of Proxies below. | ||
25. Q. | How can I obtain copies of BEIs periodic and current reports filed with the SEC? | |
A. | Our periodic and current reports are available, free of charge, on BEIs website at http://www.beverlycorp.com1 as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. | |
26. Q. | How can I obtain copies of BEIs Corporate Governance Guidelines, Audit and Compliance Committee Charter and Nominating and Compensation Committee Charter? | |
A. | Our Corporate Governance Guidelines, Audit and Compliance Committee Charter and Nominating and Compensation Committee Charter are available, free of charge, on BEIs website at http://www.beverlycorp.com. We will also provide copies of these documents in printed form at the request of any stockholder. | |
27. Q. | Has BEI adopted a Code of Business Conduct and Ethics, and if so, how can I obtain a copy? | |
A. | In early 2004, we adopted an amended and restated Code of Business Conduct and Ethics that applies to all of our employees, officers and directors, and a Code of Ethics for Senior Financial Officers that applies to our principal executive officer, principal financial officer, controller and other persons serving similar functions. Each of these codes is available, free of charge, on BEIs website at http://www.beverlycorp.com. We will also provide a copy in printed form at the request of any stockholder. |
8
28. Q. | Does BEIs Board of Directors provide a process for stockholders to send communications to the Board? | |
A. | Stockholders may send correspondence to the Board of Directors c/o the Corporate Secretary at One Thousand Beverly Way, Fort Smith, Arkansas 72919. The Corporate Secretary will review all correspondence addressed to the Board or to any individual Board member. The Corporate Secretary will determine whether correspondence should be forwarded to the Board or would be more appropriately answered by management. The Corporate Secretary will summarize all correspondence not forwarded to the Board and make the summaries of the correspondence periodically available to the Board for its review. At the Boards request, the Corporate Secretary will provide the Board with the actual correspondence underlying the summaries. | |
29. Q. | Do I have dissenters rights? | |
A. | No dissenters rights apply to any matter to be acted upon at this meeting. |
9
10
| Between December 31, 2000 and September 30, 2004, we increased cash and cash equivalents, on a consolidated basis, from approximately $26 million to approximately $207 million. The September 30, 2004 amount includes cash of approximately $56 million related to our subsidiaries that are not guarantors of our 77/8% Senior Subordinated Notes; |
11
| From December 31, 2000 to September 30, 2004, we reduced our long-term debt (including current portion) from approximately $1 billion to approximately $570 million. These amounts include off-balance sheet obligations, if any, and obligations of our direct and indirect wholly owned subsidiaries, but do not include other current or long-term liabilities on our balance sheet; and | |
| From December 31, 2000 to September 30, 2004, through greater management focus on improving collections, including implementation of new systems and centralization of Medicare collections, we reduced our skilled nursing patient receivables from approximately $495 million to approximately $181 million. On a same facility basis (facilities operating at both December 31, 2000 and September 30, 2004), our skilled nursing receivables declined approximately 41% from $296.8 million at December 31, 2000. |
| the price of BEIs common stock has more than quadrupled between January 2003 (the beginning of the first quarter following our announcement of a two-year divestiture program that was intended to, and did, result in a significant reduction in projected patient care liability costs) and January 21, 2005 (the last trading day prior to the public disclosure of the Formation Capital letters); | |
| EBITDA2 from continuing operations (on a comparable basis) has more than tripled in the past four years; and | |
| BEI has developed innovative clinical services, including for Alzheimers patients, and focused on delivering quality care for the elderly, which the BEI Board believes will result in competitive advantages for BEI as it continues to implement its strategic plan. |
| EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; |
| EBITDA does not reflect changes in, or cash requirements for, our working capital needs; |
| EBITDA does not reflect interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; and |
| although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA does not reflect any cash requirements for such replacements. |
12
| the Whitman/ Appaloosa group did not have a commitment letter with respect to the debt financing that would be required to complete an acquisition of BEI; | |
| even if the Whitman/ Appaloosa group were to receive a commitment letter with respect to debt financing, it would almost certainly be subject to numerous qualifications and conditions, which would likely include both customary financing conditions and conditions specifically related to the complex multi-property real estate financing the BEI Board believes would be required to finance the Whitman/ Appaloosa groups proposal for an acquisition of BEI. For example, as disclosed in Mariner Health Care, Inc. public filings, even after the acquirer of Mariner, another operator of skilled nursing facilities, conducted almost two months of due diligence (as compared with the 30 days of due diligence the Whitman/ Appaloosa group indicated it required in its December 22 letter), the debt commitment letter provided to the acquirers of Mariner was conditioned upon, among other things, real estate, healthcare and legal and financial due diligence acceptable to the lender; | |
| exploration of even the feasibility of the financing required to complete either of the transactions would require protracted and undefined due diligence that would disrupt our operations; | |
| rising interest rates and attendant changes in the capital markets (including the availability and cost of leveraged financing, based on either cash flows or real estate assets) create additional uncertainty with respect to the ability to obtain the required debt financing; | |
| the proposed prices suggested in the two letters are subject to, among other things, the Whitman/ Appaloosa groups completion of business, regulatory, legal and accounting due diligence; | |
| while the letters suggest that the Whitman/ Appaloosa group might raise the proposed purchase price, the terms of their letters are not binding and the group may attempt to lower their proposed purchase price; and | |
| the indications of interest by the Whitman/ Appaloosa group were also subject to negotiation of definitive documentation as described in the December 22 letter. |
13
| FOR the BEI director nominees; and | |
| AGAINST items 3-5 on the enclosed WHITE proxy card. |
| following the transfer, the health facility will continue to be able to meet the needs of the locale or area in terms of health care required for the population or geographic region; | |
| the health facility can be adequately staffed and operated when the transfer is completed; | |
| the proposed transfer is economically feasible; | |
| the health facility will foster cost containment through improved efficiency and productivity following the transfer; and | |
| following the transfer the applicant can be expected to provide a substantially consistent high level of care at the health facility. | |
14
15
1. | Election of Directors |
2. | Ratification of the Appointment of Ernst & Young LLP as our Independent Registered Public Accounting Firm for 2005 |
Audit Fees |
Audit-Related Fees |
Tax Fees |
All Other Fees |
Pre-Approval Policy for Audit and Non-Audit Services Performed by Independent Registered Public Accounting Firm |
16
17
Name of Director/Nominee | Position | Age | Director Since | |||||||
William R. Floyd
|
Chairman of the Board, President, Chief Executive Officer and Director |
60 | July 2000 | |||||||
Melanie Creagan Dreher, Ph.D.
|
Director | 61 | August 2004 | |||||||
John D. Fowler, Jr.
|
Director | 47 | February 2002 | |||||||
John P. Howe, III, M.D.
|
Director | 61 | July 2001 | |||||||
James W. McLane
|
Director | 66 | October 2000 | |||||||
Ivan R. Sabel
|
Director | 59 | March 2004 | |||||||
Donald L. Seeley
|
Director | 60 | April 2002 | |||||||
Marilyn R. Seymann, Ph.D.
|
Director | 62 | March 1995 |
18
19
Audit and | Nominating and | ||||||||||||||||||||
Name | Board | Compliance | Compensation | Quality | Finance | ||||||||||||||||
William R. Floyd
|
X | * | |||||||||||||||||||
Melanie Creagan Dreher, Ph.D.
|
X | X | |||||||||||||||||||
John D. Fowler, Jr.
|
X | X | X | * | X | ||||||||||||||||
John P. Howe, III, M.D.
|
X | X | (a) | X | * | ||||||||||||||||
James W. McLane
|
X | X | X | X | * | ||||||||||||||||
Ivan R. Sabel
|
X | X | X | X | |||||||||||||||||
Donald L. Seeley
|
X | X, E | * | X | X | ||||||||||||||||
Marilyn R. Seymann, Ph.D.
|
X | X | (a) | X | |||||||||||||||||
Number of Meetings in 2004
|
12 | (b) | 9 | (c) | 11 | (d) | 4 | (e) | 1 | (f) |
X | Member | |
* | Chairperson | |
E | Audit committee financial expert | |
(a) | Served on committee until May 20, 2004. | |
(b) | During 2004, the Board of Directors held six meetings in person and six telephonically. | |
(c) | During 2004, the Audit and Compliance Committee held six meetings in person and three telephonically. | |
(d) | During 2004, the Nominating and Compensation Committee held six meetings in person and five telephonically. | |
(e) | During 2004, the Quality Committee held four meetings in person. | |
(f) | During 2004, the Finance Committee held one meeting telephonically. |
20
Audit and Compliance: |
oversees financial reporting process appoints, retains and oversees the work of independent registered public accounting firm reviews scope and results of audit plans and accounting practices oversees internal audit function oversees compliance function and reporting under the Corporate Integrity Agreement issues Audit and Compliance Committee Report (see p. 28) |
|
Nominating and Compensation: |
reviews and approves corporate goals and objectives
relevant to the CEO compensation; evaluates CEO performance and
determines and approves CEO compensation reviews and makes recommendations to the Board with respect to compensation matters related to other senior officers oversees compensation and benefits programs, plans, policies and practices approves goals for incentive and equity-based plans and evaluates performance issues Nominating and Compensation Committee Report (see p. 30) identifies and recommends candidates for election to Board establishes procedures and criteria for nomination develops and oversees corporate governance guidelines makes recommendations to the Board regarding governance matters makes recommendations to the Board regarding changes to BEIs certificate of incorporation, by-laws and the charters of BEIs committees develops and recommends to the Board policies and procedures related to corporate governance oversees the evaluation of the Board and management |
|
Quality:
|
oversees the development and monitoring of
regulatory and compliance programs reviews the scope and results of various BEI quality reports reports progress to the Board |
|
Finance:
|
reviews issues related to BEI financial matters reports and makes recommendations to the Board |
|
21
22
| William R. Floyd, BEIs sole employee director, received no compensation for serving on the Board, other than expense reimbursement. Mr. Floyd also receives a salary in connection with his position as BEIs Chairman of the Board, President and Chief Executive Officer. | |
| In 2004, non-employee directors, as a group, received $366,605 in cash, $256,100 credited as deferred share units, which, until May 20, 2004, included a 25% BEI match, and $18,562 credited as deferred cash units. This compensation was paid based on the following: |
Category | Participation Fees(d) | |||
Annual retainer fee
|
$ | 35,000 | ||
Additional annual retainer fee for Chairperson of Audit and
|
||||
Compliance Committee and Nominating and Compensation
|
||||
Committee (June-December)(a)
|
$ | 15,000 | ||
Additional annual retainer fee for Chairperson of Finance
|
||||
Committee and Quality Committee (June-December)(a)
|
$ | 10,000 | ||
Attendance at Board or Committee meetings (January-May)
|
$ | 1,000/500 | (e) | |
Attendance at Board meeting (June-December)
|
$ | 1,500/750 | (e) | |
Attendance at Committee meeting (June-December)
|
$ | 1,250/625 | (e) | |
Attendance at Committee meeting Chairperson
(January-May)(b)
|
$ | 1,000/500 | (e) |
Expense reimbursement
|
Out of pocket costs |
Restricted Shares(c) | Value at Time of Grant | |||
15,385 shares
|
$ | 120,000 |
(a) | The respective Chairpersons were paid a prorated amount of the annual retainer fee in 2004. | |
(b) | The Committee Chairperson received this amount in addition to the amount received for attendance at Committee meetings generally. This per meeting fee was replaced in June 2004 by the annual retainer fee referred to in footnote (a). | |
(c) | In accordance with the Non-Employee Directors Stock Option Plan, non-employee directors receive annual restricted shares grant equal to $120,000, as determined based on the closing share price on the date of the Board meeting held in conjunction with the Annual Meeting. Dr. Dreher received 11,688 shares, pro rated from August when she joined the Board. Directors may choose to defer the grant of all or a portion of these shares. Deferred restricted shares are designated as phantom stock units. Each phantom stock unit has an initial value equivalent to one share of BEI common stock and directly tracks the increase or decrease in value of BEIs common stock. Distributions will be made in shares of BEI common stock, and will start upon retirement, termination, death or disability and can be made, at the directors option, in a lump sum or over a period of two to 10 years. | |
(d) | In accordance with the Non-Employee Director Deferred Compensation Plan, non-employee directors are permitted to defer all or a portion of their cash compensation. Deferred compensation is designated as phantom stock units, cash units or a combination of both. Each phantom stock unit has an initial value equivalent to one share of BEI common stock and directly tracks the increase or decrease in value of BEIs common stock. Cash units accrue interest at the prime rate, as determined by a major New York bank, on the first business day of the year. All of the deferred cash in 2004 constituted interest earned on cash deferred in previous years. Distributions will be made in shares of BEI common stock, and will start upon retirement, termination, death or disability and can be made, at the directors option, in a lump sum or over a period of two to 10 years. | |
(e) | If two amounts are shown, the first amount represents the participation fee if the non-employee director attended the applicable meeting in the manner in which attendance was requested, while the second amount represents attendance in any other manner. |
23
Name | Position | Age | ||||
William R. Floyd
|
Chairman of the Board, President, Chief Executive Officer and Director | 60 | ||||
Douglas J. Babb
|
Executive Vice President and Chief Administrative and Legal Officer | 52 | ||||
David R. Devereaux
|
Executive Vice President and Chief Operating Officer Nursing Facilities | 42 | ||||
Jeffrey P. Freimark
|
Executive Vice President, Chief Financial and Information Officer | 49 | ||||
Cindy H. Susienka
|
Executive Vice President and Chief Operating Officer Aegis and AseraCare | 45 | ||||
Patrice K. Acosta
|
Senior Vice President Quality of Life Programs | 48 | ||||
Pamela H. Daniels
|
Senior Vice President, Controller and Chief Accounting Officer | 41 | ||||
Lawrence Deans
|
Senior Vice President Human Resources | 53 | ||||
James M. Griffith
|
Senior Vice President Investor Relations and Corporate Communications | 62 | ||||
Patricia C. Kolling
|
Senior Vice President Compliance | 58 | ||||
Andrea J. Ludington
|
Senior Vice President Professional Services | 59 | ||||
Barbara R. Paul, M.D.
|
Senior Vice President and Chief Medical Officer | 51 | ||||
Harold A. Price, Ph.D.
|
Senior Vice President Sales and Business Development | 55 | ||||
Chris W. Roussos
|
President AseraCare | 40 | ||||
Martha J. Schram
|
President Aegis Therapies | 53 | ||||
Richard D. Skelly, Jr.
|
Senior Vice President and Treasurer | 45 | ||||
Jane A. Washburn
|
Senior Vice President and Chief Marketing Officer | 50 |
24
25
Shares Beneficially | Percent of | ||||||||
Name and Address of Beneficial Owner | Owned | Common Stock | |||||||
Appaloosa Investment Limited Partnership I,
et al.(1)(2)
|
8,737,000 | 8.10% | |||||||
c/o Appaloosa Partners, Inc. | |||||||||
26 Main Street, 1st Floor | |||||||||
Chatham, NJ 07928 | |||||||||
Strong Capital Management, Inc.(3)
|
6,253,247 | 5.80% | |||||||
100 Heritage Reserve | |||||||||
Menomonee Falls, WI 53051 | |||||||||
Barclays Global Investors(4)
|
5,402,927 | 5.03% | |||||||
45 Fremont Street | |||||||||
San Francisco, CA 94105 |
(1) | Group consisting of Appaloosa Investment Limited Partnership I, Palomino Fund Ltd., Appaloosa Management L.P., Appaloosa Partners Inc., David A. Tepper, Franklin Mutual Advisers, LLC, Northbrook NBV, LLC, David Hokin, Rob Rubin, Robert Hartman, 1995 David Reis Family Trust, 1995 Donna Reis Family Trust, Aaron Reis Spray Trust, Anna Reis Spray Trust, Alexander Reis Spray Trust, David Reis Family Trust, David Reis, Baylor Enterprises LLC and Arnold M. Whitman. |
(2) | Based on information contained in a Schedule 13D/ A filed by the Whitman/ Appaloosa group with the SEC on February 22, 2005. |
(3) | Based on a Schedule 13G/ A filed by Strong Capital Management, Inc. with the SEC on February 11, 2005. |
(4) | Based on a Schedule 13G filed by Barclays Global Investors, N.A. with the SEC on February 17, 2004. |
Total | ||||||||||||||||||||||||
Sole Voting | Options | Number of | Percentage | |||||||||||||||||||||
and | Exercisable | Other | Shares | of | ||||||||||||||||||||
Investment | Within | Beneficial | Deferred | Beneficially | Common | |||||||||||||||||||
Name and Address(1) | Power(2) | 60 Days(3) | Ownership(4) | Compensation(5) | Owned | Stock | ||||||||||||||||||
William R. Floyd
|
660,880 | 1,350,000 | | | 2,010,880 | 1.85 | % | |||||||||||||||||
David R. Devereaux(6)
|
119,722 | (7) | 242,830 | | | 362,552 | * | |||||||||||||||||
Douglas J. Babb
|
182,901 | 359,900 | | | 542,801 | * | ||||||||||||||||||
Jeffrey P. Freimark
|
166,106 | 262,500 | 6,450 | | 435,056 | * | ||||||||||||||||||
Cindy H. Susienka
|
118,777 | (7) | 212,925 | | | 331,702 | * | |||||||||||||||||
John D. Fowler, Jr.
|
5,000 | 25,667 | | 67,010 | 97,677 | * | ||||||||||||||||||
Marilyn R. Seymann, Ph.D.
|
16,385 | 56,625 | | 21,933 | 94,943 | * | ||||||||||||||||||
John P. Howe, III, M.D.
|
| 32,083 | | 43,269 | 75,352 | * | ||||||||||||||||||
James W. McLane
|
15,385 | 34,968 | | 21,597 | 71,950 | * | ||||||||||||||||||
Donald L. Seeley
|
38,385 | 23,833 | | | 62,218 | * | ||||||||||||||||||
Ivan R. Sabel
|
| 2,750 | | 23,925 | 26,675 | * | ||||||||||||||||||
Melanie Creagan Dreher, Ph.D.
|
| | | 12,662 | 12,662 | * | ||||||||||||||||||
All directors and executive officers as a group
(24 persons)(8)
|
2,038,349 | (7) | 3,195,381 | 6,700 | 190,396 | 5,430,825 | 4.99 | % |
* | Percentage of BEI common stock owned does not exceed 1%. |
(1) | The address of each person is One Thousand Beverly Way, Fort Smith, Arkansas 72919. |
26
(2) | Includes shares of restricted stock in the following amounts: William R. Floyd (467,322); David R. Devereaux (69,189); Douglas J. Babb (135,171); Jeffrey P. Freimark (138,376); Cindy H. Susienka (89,358); Marilyn R. Seymann, Ph.D. (15,385); James W. McLane (15,385); Donald L. Seeley (15,385) and all directors and executive officers as a group 1,354,734. Does not include phantom stock units issued under the Non-Employee Director Deferred Compensation Plan, all of which will be distributed as shares of BEI common stock upon the applicable distribution dates (converted on a one-for-one basis), in the following amounts: Melanie Creagan Dreher, Ph.D. 12,662; John D. Fowler, Jr. (67,010); John P. Howe, III, M.D. 43,269; James W. McLane (21,597); Ivan R. Sabel 23,925; and Marilyn R. Seymann, Ph.D. (21,933). Also does not include cash units issued under the Non-Employee Director Deferred Compensation Plan, all of which will be distributed as shares of BEI common stock on the applicable distribution dates. |
(3) | Total options held (including options exercisable within 60 days) are as follows: William R. Floyd (1,500,000); David R. Devereaux (278,456); Douglas J. Babb (422,400); Jeffrey P. Freimark (300,000); Cindy H. Susienka (238,700); John D. Fowler, Jr. (25,667); Marilyn R. Seymann, Ph.D. (56,625); John P. Howe, III, M.D. (32,083); James W. McLane (34,968); Donald L. Seeley (23,833); Ivan R. Sabel (2,750) and all directors and executive officers as a group (3,645,157). |
(4) | Represents shares owned by family members. |
(5) | Represents total shares of BEI common stock reserved for distribution under the Non-Employee Director Deferred Compensation Plan. |
(6) | This table does not include 119,722 shares, and options exercisable for an additional 131,419 shares, transferred by Mr. Devereaux in early February 2005 pursuant to a domestic relations order. |
(7) | Includes shares purchased under the Employee Stock Purchase Plan in the following amounts: David R. Devereaux (823); Cindy H. Susienka (685) and all directors and officers as a group 12,569. |
(8) | Excludes restricted stock granted on March 10, 2005 in the following amounts: William R. Floyd (188,442); David R. Devereaux (38,275); Douglas J. Babb (36,097); Jeffrey P. Freimark (38,275); and Cindy H. Susienka (32,245). |
27
28
AUDIT AND COMPLIANCE COMMITTEE | |
Donald L. Seeley, Chairperson | |
James W. McLane | |
John D. Fowler, Jr. | |
Marilyn R. Seymann, Ph.D. |
29
| quality of care will always be a key criteria in the formulation of incentive compensation; | |
| competitive market for executive talent is national and multi-industry in scope; | |
| pay should position salary around competitive market median and target incentive pay around the 75th percentile, with opportunity to exceed this level with strong performance; | |
| pay should consist of cash and stock-based vehicles; | |
| pay is tied to performance; | |
| pay should reflect significant upside for exceeding goals; and | |
| individual contributions should be recognized. |
30
31
32
33
NOMINATING AND COMPENSATION COMMITTEE | |
John D. Fowler, Jr., Chairperson | |
James W. McLane | |
Ivan R. Sabel | |
Marilyn R. Seymann, Ph.D. |
34
Long-Term | |||||||||||||||||||||||||||||||||
Compensation | |||||||||||||||||||||||||||||||||
Awards Payouts | |||||||||||||||||||||||||||||||||
Annual Compensation | Restricted | Securities | |||||||||||||||||||||||||||||||
Other Annual | Stock | Underlying | LTIP | All Other | |||||||||||||||||||||||||||||
Fiscal | Salary | Bonus | Compensation | Awards | Options | Payouts | Compensation | ||||||||||||||||||||||||||
Name and Principal Position | Year | ($) | ($)(1) | ($) | ($)(11) | (#) | ($) | ($) | |||||||||||||||||||||||||
William R. Floyd
|
2004 | 882,301 | 1,344,375 | (2) | | 1,675,612 | | 208,417 | 1,846,668 | (12) | |||||||||||||||||||||||
Chairman of the Board- | 2003 | 834,591 | 1,337,414 | (2) | | 654,431 | | | 139,904 | (13) | |||||||||||||||||||||||
President and Chief | 2002 | 835,000 | | | 1,426,250 | 600,000 | | 36,126 | (14) | ||||||||||||||||||||||||
Executive Officer | |||||||||||||||||||||||||||||||||
Douglas J. Babb
|
2004 | 425,771 | 386,284 | | 404,336 | | 81,392 | 546,790 | (15) | ||||||||||||||||||||||||
Executive Vice President- | 2003 | 402,786 | 420,949 | | 261,250 | | | 72,003 | (16) | ||||||||||||||||||||||||
Chief Administrative and | 2002 | 377,692 | | | | 250,000 | | 10,976 | (17) | ||||||||||||||||||||||||
Legal Officer | |||||||||||||||||||||||||||||||||
David R. Devereaux(3)
|
2004 | 444,557 | 409,586 | | 429,343 | | 91,813 | 866,616 | (18) | ||||||||||||||||||||||||
Chief Operating Officer- | 2003 | 427,699 | 446,986 | | 261,250 | | | 61,608 | (19) | ||||||||||||||||||||||||
Nursing Facilities | 2002 | 413,846 | | | | 190,000 | | 78,720 | (20) | ||||||||||||||||||||||||
Jeffrey P. Freimark
|
2004 | 451,575 | 409,586 | (4) | 431,967 | (7) | 429,335 | | 91,809 | 600,250 | (21) | ||||||||||||||||||||||
Executive Vice President, | 2003 | 427,690 | 446,976 | (4) | 70,758 | (8) | 261,250 | | | 72,669 | (22) | ||||||||||||||||||||||
Chief Financial and | 2002 | 415,192 | 150,000 | (5) | 94,482 | (9) | | 150,000 | | 67,108 | (23) | ||||||||||||||||||||||
Information Officer | |||||||||||||||||||||||||||||||||
Cindy H. Susienka
|
2004 | 385,000 | 345,056 | (6) | | 384,992 | | 68,333 | 361,477 | (24) | |||||||||||||||||||||||
Executive Vice President- | 2003 | 330,439 | 302,837 | (6) | | 125,400 | | | 35,002 | (25) | |||||||||||||||||||||||
and Chief Operating Officer Aegis and AseraCare | 2002 | 319,231 | | 7,313 | (10) | | 80,000 | | 4,772 | (26) |
(1) | Bonus amounts, if any, are listed for the year in which they were earned; such amounts were paid in the following year. | |
(2) | $627,188 and $668,707 was deferred in 2004 and 2003, respectively, under the Executive Deferred Compensation Plan. | |
(3) | In early February, 2005, Mr. Devereaux transferred one-half of his common stock (119,722 shares) together with 40% of all vested and 25% of all unvested options (exercisable for 72,209 and 54,210 shares of common stock, respectively) pursuant to a domestic relations order. | |
(4) | $81,987 and $89,395 was deferred in 2004 and 2003, respectively, under the Executive Deferred Compensation Plan. | |
(5) | Mr. Freimark received a guaranteed bonus of $150,000 pursuant to his employment agreement. | |
(6) | $86,264 and $75,709 was deferred in 2004 and 2003, respectively, under the Executive Deferred Compensation Plan. | |
(7) | Includes: (i) relocation costs and expenses paid to or on behalf of Mr. Freimark in connection with his relocation from New Jersey to Arkansas of $395,468; and (ii) gross-up for taxes related to forgiveness of debt of $36,499. | |
(8) | Includes: (i) relocation costs and expenses paid to or on behalf of Mr. Freimark in connection with his relocation from New Jersey to Arkansas of $33,988; and (ii) gross-up for taxes related to the forgiveness of debt of $36,770. | |
(9) | Includes: (i) relocation costs and expenses paid to or on behalf of Mr. Freimark in connection with his relocation from New Jersey to Arkansas; and (ii) gross- up for taxes related to the forgiveness of debt $44,781. |
(10) | Relocation costs and expenses paid to or on behalf of Ms. Susienka in connection with her relocation from Arkansas to Wisconsin. |
(11) | See Restricted Stock table following this Summary Compensation Table. |
(12) | Includes: (i) Regular Life Insurance Plan $6,241 (see footnote 27); (ii) BEI contribution to the Retention Enhancement Plan $604,102; (iii) vesting of restricted stock $1,187,138; (iv) personal use of BEI plane $13,128; and (v) BEI contribution to the Executive Allowance Plan $36,059. |
(13) | Includes: (i) Executive Medical Plan $213; (ii) Regular Life Insurance Plan $4,064 (see footnote 27); (iii) personal use of BEI plane $6,127; and (iv) vesting of restricted stock $129,500. |
(14) | Includes: (i) Executive Medical Plan $2,804; (ii) premiums under Executive Life Insurance Plan $3,396 (see footnote 28); (iii) Regular Life Insurance Plan $4,051 (see footnote 27); (iv) benefit allowance $2,813 (see footnote 29); (v) personal use of BEI plane $14,201; and (vi) Executive Disability Policy $8,861. |
(15) | Includes: (i) Regular Life Insurance Plan $980 (see footnote 27); (ii) BEI contribution to the Executive Deferred Compensation Plan $30,326; (iii) BEI contribution to the Enhanced Supplemental Executive Retirement Plan $178,909; (iv) vesting of restricted stock $319,169; and (v) BEI contribution to the Executive Allowance Plan $17,406. |
35
(16) | Includes: (i) Executive Medical Plan $27; (ii) Regular Life Insurance Plan $978 (see footnote 27); and (iii) BEI contribution to the Executive Deferred Compensation Plan $70,998. |
(17) | Includes: (i) Executive Medical Plan $5,045; (ii) premiums under Executive Life Insurance Plan $690 (see footnote 28); (iii) Regular Life Insurance Plan $900 (see footnote 27); and (iv) benefit allowance $4,341 (see footnote 29). |
(18) | Includes: (i) Regular Life Insurance Plan $456 (see footnote 27); (ii) BEI contribution to the Executive Deferred Compensation Plan $21,468; (iii) BEI contribution to the Enhanced Supplemental Executive Retirement Plan $184,031; (iv) vesting of restricted stock $660,267; and (v) personal use of BEI plane $394. |
(19) | Includes: (i) Executive Medical Plan $1,326; (ii) Regular Life Insurance Plan $455 (see footnote 27); (iii) vesting of restricted stock $15,859; (iv) BEI contribution to the Executive Deferred Compensation Plan $21,250; and (v) distribution from the previous Executive Deferred Compensation Plan $22,718. |
(20) | Includes: (i) matching contribution to Employee Stock Purchase Plan $255; (ii) Executive Medical Plan $4,656; (iii) Regular Life Insurance Plan $436 (see footnote 27); (iv) benefit allowance $4,346 (see footnote 29); and (v) vesting of restricted stock $69,027. |
(21) | Includes: (i) Regular Life Insurance Plan $684 (see footnote 27); (ii) BEI contribution to the Executive Deferred Compensation Plan $21,467; (iii) BE contribution to the Enhanced Supplemental Executive Retirement Plan $189,835; (iv) vesting of restricted stock $319,169; (v) forgiveness of debt $50,445; (vi) personal use of BEI plane $194; and (vii) BEI contribution to the Executive Allowance Plan $18,456. |
(22) | Includes: (i) Regular Life Insurance Plan $683 (see footnote 27); (ii) forgiveness of debt $50,736; and (iii) BEI contribution to the Executive Deferred Compensation Plan $21,250. |
(23) | Includes: (i) Executive Medical Plan $5,603; (ii) Regular Life Insurance Plan $506 (see footnote 27); (iii) benefit allowance $2,799 (see footnote 29); (iv) personal use of BEI plane $2,053; (v) forgiveness of debt $53,919; and (vi) COBRA reimbursement $2,228. |
(24) | Includes: (i) Regular Life Insurance Plan $504 (see footnote 27); (ii) BEI contribution to the Executive Deferred Compensation Plan $19,250; (iii) BEI contribution to the Enhanced Supplemental Executive Retirement Plan $144,446; (iv) vesting of restricted stock $181,629; (v) non-cash compensable item granted to several employees, including Ms. Susienka, in connection with the completion of an enterprise-wide project $100; and (vi) BEI contribution to the Executive Allowance Plan $15,548. |
(25) | Includes: (i) Executive Medical Plan $1,914; (ii) Regular Life Insurance Plan $335 (see footnote 27); (iii) personal use of BEI plane $1,011; (iv) BEI contribution to the Executive Deferred Compensation Plan $16,250; and (v) distribution from the previous Executive Deferred Compensation Plan $15,492. |
(26) | Includes: (i) benefit allowance $2,813 (see footnote 29); (ii) Executive Medical Plan $1,256; (iii) matching contribution to Employee Stock Purchase Plan $383; and (iv) premiums under Executive Life Insurance Plan $320 (see footnote 28). |
(27) | Imputed income for life insurance provided under BEIs regular life insurance plan for amounts in excess of $50,000. |
(28) | Amount shown represents the taxable benefit under split-dollar life insurance policies. Messrs. Devereaux and Freimark did not participate in this plan. |
(29) | Reimbursement for premiums paid under regular medical and dental insurance. |
36
Number of | ||||||||||||||
Number of | Restricted | |||||||||||||
Restricted Shares | Value of Restricted | Shares Granted | ||||||||||||
Held as of | Shares Held as of | in the Three | ||||||||||||
Name | 12/31/04(1) | 12/31/04(2) | Prior Years | Vesting Schedule | ||||||||||
William R. Floyd
|
511,072 | $ | 4,676,309 | 214,822 | This award was granted on May 20, 2004. 100% of this award becomes fully vested three years from the date of grant. | |||||||||
313,125 | This award was granted on April 1, 2003. 104,375, or 33.33%, of the restricted shares vested on May 10, 2004. The remaining 208,760 shares of restricted stock will become fully vested in the amount of 104,375 shares per anniversary thereafter. | |||||||||||||
175,000 | This award was granted on January 2, 2002. 43,750 of the restricted shares vested on the first and second anniversaries of the grant date, respectively. The remaining 87,500 shares of restricted stock will become fully vested in the amount of 43,750 shares per anniversary thereafter. | |||||||||||||
Douglas J. Babb
|
135,171 | $ | 1,236,815 | 51,838 | This award was granted on May 20, 2004. 100% of this award becomes fully vested three years from the date of grant. | |||||||||
125,000 | This award was granted on April 1, 2003. 41,667, or 33.33%, of the restricted shares vested on May 10, 2004. The remaining 83,333 shares of restricted stock will become fully vested in the amount of 41,667 shares and 41,666 shares, respectively, on the next two anniversaries of the date of grant. | |||||||||||||
David R. Devereaux(3)
|
138,377 | $ | 1,266,150 | 55,044 | This award was granted on May 20, 2004. 100% of this award becomes fully vested three years from the date of grant. | |||||||||
125,000 | This award was granted on April 1, 2003. 41,667, or 33.33%, of the restricted shares vested on May 10, 2004. The remaining 83,333 shares of restricted stock will become fully vested in the amount of 41,667 shares and 41,666 shares, respectively, on the next two anniversaries of the date of grant. | |||||||||||||
Jeffrey P. Freimark
|
138,376 | $ | 1,266,140 | 55,043 | This award was granted on May 20, 2004. 100% of this award becomes fully vested three years from the date of grant. | |||||||||
125,000 | This award was granted on April 1, 2003. 41,667, or 33.33%, of the restricted shares vested on May 10, 2004. The remaining 83,333 shares of restricted stock will become fully vested in the amount of 41,667 shares and 41,666 shares, respectively, on the next two anniversaries of the date of grant. |
37
Number of | ||||||||||||||
Number of | Restricted | |||||||||||||
Restricted Shares | Value of Restricted | Shares Granted | ||||||||||||
Held as of | Shares Held as of | in the Three | ||||||||||||
Name | 12/31/04(1) | 12/31/04(2) | Prior Years | Vesting Schedule | ||||||||||
Cindy H. Susienka
|
89,358 | $ | 817,626 | 49,358 | This award was granted on May 20, 2004. 100% of this award becomes fully vested three years from the date of grant. | |||||||||
60,000 | This award was granted on April 1, 2003. 20,000, or 33.33%, of the restricted shares vested on May 10, 2004. The remaining 40,000 shares of restricted stock will become fully vested in the amount of 20,000 shares per anniversary thereafter. |
(1) | Recipients are entitled to receive dividends on, and to vote, the restricted stock. |
(2) | Calculated based on the closing price of BEI common stock on the NYSE on December 31, 2004, which was $9.15. |
(3) | In early February, 2005, Mr. Devereaux transferred one-half of his common stock (119,722 shares) pursuant to a domestic relations order. |
38
Number of Securities | Value of Unexercised | |||||||||||||||
Underlying Unexercised | In-The-Money | |||||||||||||||
Options FY-End (12/31/04) | Options FY-End (12/31/04)(1) | |||||||||||||||
Name | Exercisable | Unexercisable | Exercisable | Unexercisable | ||||||||||||
William R. Floyd
|
1,050,000 | 450,000 | $ | 2,904,000 | $ | 603,000 | ||||||||||
Douglas J. Babb
|
275,550 | 146,850 | 982,303 | 439,330 | ||||||||||||
David R. Devereaux
|
193,025 | 216,850 | 613,593 | 410,330 | ||||||||||||
Jeffrey P. Freimark
|
112,500 | 187,500 | 61,875 | 283,125 | ||||||||||||
Cindy H. Susienka
|
187,875 | 50,825 | 327,980 | 137,090 |
(1) | Calculated based on the aggregate amount of the excess of the closing price of BEI common stock on the NYSE at December 31, 2004, which was $9.15, over the exercise price for each option. |
Estimated Future Payouts Under | |||||||||||||||||||||
Number of Shares, | Performance Or | Non-Stock Price-Based Plans | |||||||||||||||||||
Units or Other | Other Period Until | ||||||||||||||||||||
Name | Rights | Maturation Or Payout | Threshold | Target | Maximum | ||||||||||||||||
William R. Floyd
|
|||||||||||||||||||||
Restricted Stock(1)
|
214,822 | 1/1/2004-12/31/2006 | |||||||||||||||||||
Performance Units(2)
|
1/1/2004-12/31/2006 | $ | 837,817 | $ | 1,675,633 | $ | 3,351,266 | ||||||||||||||
Performance Cash(3)
|
1/1/2004-12/31/2006 | $ | 837,817 | $ | 1,675,633 | $ | 3,686,393 | ||||||||||||||
Douglas J. Babb
|
|||||||||||||||||||||
Restricted Stock(1)
|
51,838 | 1/1/2004-12/31/2006 | |||||||||||||||||||
Performance Units(2)
|
1/1/2004-12/31/2006 | $ | 202,172 | $ | 404,343 | $ | 808,686 | ||||||||||||||
Performance Cash(3)
|
1/1/2004-12/31/2006 | $ | 202,172 | $ | 404,343 | $ | 889,555 | ||||||||||||||
David R. Devereaux
|
|||||||||||||||||||||
Restricted Stock(1)
|
55,044 | 1/1/2004-12/31/2006 | |||||||||||||||||||
Performance Units(2)
|
1/1/2004-12/31/2006 | $ | 214,677 | $ | 429,353 | $ | 858,706 | ||||||||||||||
Performance Cash(3)
|
1/1/2004-12/31/2006 | $ | 214,677 | $ | 429,353 | $ | 944,577 | ||||||||||||||
Jeffrey P. Freimark
|
|||||||||||||||||||||
Restricted Stock(1)
|
55,043 | 1/1/2004-12/31/2006 | |||||||||||||||||||
Performance Units(2)
|
1/1/2004-12/31/2006 | $ | 214,672 | $ | 429,344 | $ | 858,688 | ||||||||||||||
Performance Cash(3)
|
1/1/2004-12/31/2006 | $ | 214,672 | $ | 429,344 | $ | 944,557 | ||||||||||||||
Cindy H. Susienka
|
|||||||||||||||||||||
Restricted Stock(1)
|
49,358 | 1/1/2004-12/31/2006 | |||||||||||||||||||
Performance Units(2)
|
1/1/2004-12/31/2006 | $ | 192,496 | $ | 384,992 | $ | 769,984 | ||||||||||||||
Performance Cash(3)
|
1/1/2004-12/31/2006 | $ | 192,496 | $ | 384,992 | $ | 846,982 |
(1) | See the Restricted Stock section of the Executive Compensation Summary Compensation Table for a description of restricted shares held by named executive officers generally, as well as the vesting schedule for the shares listed in this table. |
(2) | The Performance Based Restricted Units program has a target of one-third the total award for the year under the Long-Term Incentive Program. Cumulative EBITDA improvement and EBITDA margin improvement are measured equally in measuring performance over the duration of the cycle. The range of payments for this component are from 50% to 200% of the target amount based on the performance against the set measures. If the minimum amount under the performance measures is not met, then the award would be zero. Upon evaluation and approval of the cycle performance, the participants are paid an amount of BEI common stock equal to the award value, based on the closing price of the stock on the date of the evaluation. |
(3) | The Performance Based Cash program has a target of one-third the total award for the year under the Long-Term Incentive Program. Cumulative EBITDA improvement and EBITDA margin improvement are measured equally in measuring performance over the duration of the cycle. The range of payments for this component are from 50% to 200% of the target amount based on the performance against the set measures. This amount is further subject to a multiple as determined on the gain in stock price during the |
39
cycle ranging from 10% to 110%. If the minimum amount under the performance measures of the cycle or the appreciation in stock price is not met, then the award would be zero. |
40
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | |||||||||||||||||||
BEVERLY ENTERPRISES, INC
|
$ | 100.00 | $ | 187.15 | $ | 196.57 | $ | 65.14 | $ | 196.34 | $ | 209.14 | ||||||||||||
S & P MIDCAP 400 INDEX
|
100.00 | 90.89 | 80.09 | 62.39 | 80.29 | 89.02 | ||||||||||||||||||
S & P HEALTH CARE FACILITIES INDEX
|
100.00 | 166.04 | 169.69 | 122.52 | 129.10 | 116.06 |
41
Number of Securities | |||||||||||||
Remaining Available for | |||||||||||||
Number of Securities to be | Future Issuance Under | ||||||||||||
Issued Upon Exercise of | Weighted-Average Exercise | Equity Compensation Plans | |||||||||||
Outstanding Options, | Price of Outstanding Options, | (excluding securities reflected | |||||||||||
Warrants and Rights | Warrants and Rights | in column (a)) | |||||||||||
Plan Category | (a) | (b) | (c) | ||||||||||
Equity compensation plans approved by security holders
|
6,562,710 | $ | 6.5612 | 7,572,030 | |||||||||
Equity compensation plans not approved by security holders
|
| | | ||||||||||
Total
|
6,562,710 | $ | 6.5612 | 7,572,030 |
(1) | There are 7,068,986 shares remaining available for issuance under the 1997 Long-Term Incentive Plan, all of which can be issued as restricted stock, restricted stock units, performance shares, performance units, bonus stock or other stock-based awards. |
(i) the acquisition of 30% or more of the outstanding voting stock of BEI by any person or entity; | |
(ii) the persons serving as directors of BEI before any contested election for the Board of BEI, or any tender or exchange offer, merger or other business combination or sale of assets, or any combination of the foregoing (a Transaction), cease to make up more than 50% of the Board of BEI or any successor to BEI or its assets; | |
(iii) the consolidation or merger with any other person or entity where BEI is not the continuing or surviving corporation; | |
(iv) any other person or entity consolidates with, or merges with BEI, and BEI is the continuing or surviving corporation and all or part of the outstanding BEI common stock is changed into or exchanged for stock or other securities of any other person or cash or any other property; |
42
(v) BEI is party to a statutory share exchange with any other person after which BEI is a subsidiary of any other person; or | |
(vi) BEI sells or otherwise transfers 50% or more of the assets or earning power of BEI and its subsidiaries (taken as a whole) to any other person or entity. |
Proposal 3 | To amend our By-Laws to fix the number of directors constituting the entire Board at eight; | |||
Proposal 4 | To repeal any amendment to our By-Laws adopted after May 29, 1997, other than the proposed amendment described above; and | |||
Proposal 5 | To require that the foregoing proposals be presented prior to the election of directors and before any other business is conducted at the Annual Meeting. |
43
| FOR BEIs nominees for director; and | |
| AGAINST the Whitman/ Appaloosa group proposals (Items 3-5 on the enclosed WHITE proxy card). |
44
45
Douglas J. Babb | |
Secretary |
46
Name | Principal Business Address | |
William R. Floyd
|
One Thousand Beverly Way, Fort Smith, Arkansas 72919 |
|
Melanie Creagan Dreher, Ph.D.
|
University of Iowa College of Nursing 101F Nursing Building Iowa City, IA 52242-1121 |
|
John D. Fowler, Jr.
|
Deutsche Bank Securities, Inc. 60 Wall St. New York, NY 10005 |
|
John P. Howe, III, M.D.
|
Project Hope 255 Carter Hall Lane Millwood, VA 22646 |
|
James W. McLane
|
HealthAxis, Inc. Towers at Williams Square 5215 North OConnor Blvd. Suite 800 Irving, TX 75039 |
|
Ivan R. Sabel
|
Hanger Orthopedic Group, Inc. Two Bethesda Metro Center, Suite 1200 Bethesda, MD 20814 |
|
Donald L. Seeley
|
University of Arizona 1130 East Helen Street Tucson, AZ 85721 |
|
Marilyn R. Seymann, Ph.D.
|
M One, Inc. 7651 S. College Ave. Tempe, AZ 85284 |
I-1
Name and Principal Business Address | Present Principal Occupation or Employment | |
James M. Griffith
|
Senior Vice President Investor Relations and Corporate Communications | |
Richard D. Skelly, Jr.
|
Senior Vice President and Treasurer |
Shares of BEI | Options to Acquire BEI | |||||||
Name of Beneficial Owner | Common Stock(a) | Common Stock(b) | ||||||
James M. Griffith
|
193,576 | 139,100 | ||||||
Richard D. Skelly, Jr.
|
70,353 | 40,000 |
(a) | Includes 54,670 and 53,043 shares of restricted stock for James M. Griffith and Richard D. Skelly, Jr., respectively, which will vest upon a change of control, and excludes 9,966 and 8,878 shares of restricted stock granted on March 10, 2005 to Mr. Griffith and Mr. Skelly, respectively. | |
(b) | The stock options will vest upon a change of control. |
I-2
Estimated Future Payouts Under | |||||||||||||||||||||
Non-Stock Price-Based Plans | |||||||||||||||||||||
Number of Shares, | Performance Or Other | ||||||||||||||||||||
Units or Other | Period Until Maturation | Threshold | Target | Maximum | |||||||||||||||||
Name | Rights | Or Payout | $ | $ | $ | ||||||||||||||||
James M. Griffith
|
|||||||||||||||||||||
Restricted Stock
|
14,670 | 1/1/2004 - 12/31/2006 | |||||||||||||||||||
Performance Units(1)
|
1/1/2004 - 12/31/2006 | $ | 57,213 | $ | 114,425 | $ | 228,850 | ||||||||||||||
Performance Cash(2)
|
1/1/2004 - 12/31/2006 | $ | 57,213 | $ | 114,425 | $ | 251,735 | ||||||||||||||
Richard D. Skelly, Jr.
|
|||||||||||||||||||||
Restricted Stock
|
13,043 | 1/1/2004 - 12/31/2006 | |||||||||||||||||||
Performance Units(1)
|
1/1/2004 - 12/31/2006 | $ | 50,868 | $ | 101,735 | $ | 203,470 | ||||||||||||||
Performance Cash(2)
|
1/1/2004 - 12/31/2006 | $ | 50,868 | $ | 101,735 | $ | 223,817 |
(1) | The Performance Based Restricted Units program has a target of one third the total value delivered for the year under the Long-Term Incentive Program. The performance is measured equally in both cumulative EBITDA and EBITDA margin improvement over the duration of the cycle. The range of payments for this component are from 50% to 200% of the target amount based on the performance against the set measures. However, if the minimum amount under the performance measures is not met, then the award would be zero. Upon evaluation and approval of the cycle, the participants are paid in stock for the equivalent amount approved under the plan and any residual between the approved award and the amount delivered in shares is paid in cash to the participant. |
(2) | The Performance Based Cash program has a target of one third the total value delivered for the year under the Long-Term Incentive Program. The performance is measured equally in both cumulative EBITDA and EBITDA margin improvement over the duration of the cycle. The range of payments for this component are from 50% to 200% of the target amount based on the performance against the set measures. This amount is further subject to a multiple as determined on the gain in stock price during the cycle ranging from 10% to 110%. However, if the minimum amount under the performance measures of the cycle or the appreciation in stock price is not met, then the award would be zero. |
Name | January 2005 | January 2006 | ||||||
William R. Floyd
|
$ | 208,416.67 | $ | 208,416.66 | ||||
Douglas J. Babb
|
$ | 81,392.00 | $ | 81,392.00 | ||||
David R. Devereaux
|
$ | 91,812.67 | $ | 91,812.66 | ||||
Jeffrey P. Freimark
|
$ | 91,808.67 | $ | 91,808.67 | ||||
Cindy H. Susienka
|
$ | 68,333.33 | $ | 68,333.33 | ||||
James M. Griffith
|
$ | 55,000.00 | $ | 55,000.00 | ||||
Richard D. Skelly, Jr.
|
$ | 43,333.33 | $ | 43,333.33 |
I-3
Date of | Transaction Type | Number of | Nature of | |||||||||||||
Name | Transaction | (Purchase/Sale) | Shares | Transaction | ||||||||||||
Douglas J. Babb
|
4/1/2003 | Purchase | 125,000 | (1 | ) | |||||||||||
5/20/2004 | Purchase | 51,838 | (1 | ) | ||||||||||||
5/10/2004 | Sale | 13,937 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 36,097 | (1 | ) | ||||||||||||
David R. Devereaux
|
2/27/2003 | Purchase | 11,473 | (7 | ) | |||||||||||
4/1/2003 | Purchase | 125,000 | (1 | ) | ||||||||||||
5/20/2004 | Purchase | 55,044 | (1 | ) | ||||||||||||
2/27/2003 | Sale | 1,192 | (4 | ) | ||||||||||||
2/27/2003 | Sale | 11,473 | (7 | ) | ||||||||||||
4/30/2003 | Sale | 2,943 | (2 | ) | ||||||||||||
5/10/2004 | Sale | 13,833 | (2 | ) | ||||||||||||
8/18/2004 | Sale | 15,200 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 38,275 | (1 | ) | ||||||||||||
Melanie Creghan Dreher, Ph.D.
|
9/1/2004 | Purchase | 153 | (5 | ) | |||||||||||
10/1/2004 | Purchase | 97 | (5 | ) | ||||||||||||
11/1/2004 | Purchase | 163 | (5 | ) | ||||||||||||
12/1/2004 | Purchase | 80 | (5 | ) | ||||||||||||
1/3/2005 | Purchase | 197 | (5 | ) | ||||||||||||
2/1/2005 | Purchase | 105 | (5 | ) | ||||||||||||
3/1/2005 | Purchase | 180 | (5 | ) | ||||||||||||
William R. Floyd
|
4/1/2003 | Purchase | 313,125 | (1 | ) | |||||||||||
5/20/2004 | Purchase | 214,822 | (1 | ) | ||||||||||||
1/2/2004 | Sale | 15,249 | (2 | ) | ||||||||||||
5/10/2004 | Sale | 34,913 | (2 | ) | ||||||||||||
1/2/2005 | Sale | 14,996 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 188,442 | (1 | ) | ||||||||||||
John D. Fowler, Jr.
|
3/3/2003 | Purchase | 4,503 | (5 | ) | |||||||||||
4/1/2003 | Purchase | 3,539 | (5 | ) | ||||||||||||
5/1/2003 | Purchase | 1,851 | (5 | ) | ||||||||||||
6/2/2003 | Purchase | 11,000 | (6 | ) | ||||||||||||
6/2/2003 | Purchase | 2,375 | (5 | ) | ||||||||||||
7/1/2003 | Purchase | 1,224 | (5 | ) | ||||||||||||
8/1/2003 | Purchase | 1,321 | (5 | ) | ||||||||||||
9/2/2003 | Purchase | 701 | (5 | ) | ||||||||||||
10/2/2003 | Purchase | 811 | (5 | ) | ||||||||||||
11/3/2003 | Purchase | 1,165 | (5 | ) | ||||||||||||
12/1/2003 | Purchase | 934 | (5 | ) | ||||||||||||
1/2/2004 | Purchase | 976 | (5 | ) | ||||||||||||
2/2/2004 | Purchase | 675 | (5 | ) | ||||||||||||
2/2/2004 | Purchase | 612 | (5 | ) | ||||||||||||
3/1/2004 | Purchase | 1,121 | (5 | ) | ||||||||||||
4/1/2004 | Purchase | 1,694 | (5 | ) |
I-4
Date of | Transaction Type | Number of | Nature of | |||||||||||||
Name | Transaction | (Purchase/Sale) | Shares | Transaction | ||||||||||||
5/3/2004 | Purchase | 1,165 | (5 | ) | ||||||||||||
5/20/2004 | Purchase | 15,385 | (5 | ) | ||||||||||||
6/1/2004 | Purchase | 1,140 | (5 | ) | ||||||||||||
7/1/2004 | Purchase | 794 | (5 | ) | ||||||||||||
8/2/2004 | Purchase | 538 | (5 | ) | ||||||||||||
9/1/2004 | Purchase | 1,145 | (5 | ) | ||||||||||||
10/1/2004 | Purchase | 553 | (5 | ) | ||||||||||||
11/1/2004 | Purchase | 940 | (5 | ) | ||||||||||||
12/1/2004 | Purchase | 592 | (5 | ) | ||||||||||||
1/3/2005 | Purchase | 1,006 | (5 | ) | ||||||||||||
Jeffrey P. Freimark
|
4/1/2003 | Purchase | 125,000 | (1 | ) | |||||||||||
5/20/2004 | Purchase | 55,043 | (1 | ) | ||||||||||||
5/10/2004 | Sale | 13,937 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 38,275 | (1 | ) | ||||||||||||
James M. Griffith
|
2/27/2003 | Purchase | 30 | (3 | ) | |||||||||||
2/27/2003 | Purchase | 7,000 | (8 | ) | ||||||||||||
2/27/2003 | Purchase | 3,000 | (8 | ) | ||||||||||||
2/27/2003 | Purchase | 14,236 | (7 | ) | ||||||||||||
4/1/2003 | Purchase | 60,000 | (1 | ) | ||||||||||||
5/20/2004 | Purchase | 14,670 | (1 | ) | ||||||||||||
2/27/2003 | Sale | 14,236 | (7 | ) | ||||||||||||
5/10/2004 | Sale | 6,690 | (2 | ) | ||||||||||||
8/18/2004 | Sale | 18,612 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 9,966 | (1 | ) | ||||||||||||
John P. Howe, III, M.D.
|
3/3/2003 | Purchase | 2,903 | (5 | ) | |||||||||||
4/1/2003 | Purchase | 1,022 | (5 | ) | ||||||||||||
5/1/2003 | Purchase | 925 | (5 | ) | ||||||||||||
6/2/2003 | Purchase | 11,000 | (6 | ) | ||||||||||||
6/2/2003 | Purchase | 844 | (5 | ) | ||||||||||||
7/1/2003 | Purchase | 612 | (5 | ) | ||||||||||||
8/1/2003 | Purchase | 437 | (5 | ) | ||||||||||||
9/2/2003 | Purchase | 261 | (5 | ) | ||||||||||||
10/2/2003 | Purchase | 405 | (5 | ) | ||||||||||||
11/3/2003 | Purchase | 484 | (5 | ) | ||||||||||||
12/1/2003 | Purchase | 309 | (5 | ) | ||||||||||||
1/2/2004 | Purchase | 417 | (5 | ) | ||||||||||||
2/2/2004 | Purchase | 675 | (5 | ) | ||||||||||||
2/2/2004 | Purchase | 228 | (5 | ) | ||||||||||||
3/1/2004 | Purchase | 480 | (5 | ) | ||||||||||||
4/1/2004 | Purchase | 515 | (5 | ) | ||||||||||||
5/3/2004 | Purchase | 582 | (5 | ) | ||||||||||||
5/20/2004 | Purchase | 15,385 | (5 | ) | ||||||||||||
6/1/2004 | Purchase | 426 | (5 | ) | ||||||||||||
7/1/2004 | Purchase | 223 | (5 | ) | ||||||||||||
8/2/2004 | Purchase | 242 | (5 | ) | ||||||||||||
9/1/2004 | Purchase | 553 | (5 | ) | ||||||||||||
10/1/2004 | Purchase | 249 | (5 | ) | ||||||||||||
11/1/2004 | Purchase | 374 | (5 | ) | ||||||||||||
12/1/2004 | Purchase | 205 | (5 | ) | ||||||||||||
1/3/2005 | Purchase | 439 | (5 | ) | ||||||||||||
2/1/2005 | Purchase | 275 | (5 | ) | ||||||||||||
3/1/2005 | Purchase | 395 | (5 | ) | ||||||||||||
James. W. McLane
|
3/3/2003 | Purchase | 963 | (5 | ) | |||||||||||
4/1/2003 | Purchase | 1,333 | (5 | ) |
I-5
Date of | Transaction Type | Number of | Nature of | |||||||||||||
Name | Transaction | (Purchase/Sale) | Shares | Transaction | ||||||||||||
5/1/2003 | Purchase | 463 | (5 | ) | ||||||||||||
6/2/2003 | Purchase | 11,000 | (6 | ) | ||||||||||||
6/2/2003 | Purchase | 594 | (5 | ) | ||||||||||||
7/1/2003 | Purchase | 306 | (5 | ) | ||||||||||||
8/1/2003 | Purchase | 274 | (5 | ) | ||||||||||||
9/2/2003 | Purchase | 131 | (5 | ) | ||||||||||||
10/2/2003 | Purchase | 203 | (5 | ) | ||||||||||||
11/3/2003 | Purchase | 291 | (5 | ) | ||||||||||||
12/1/2003 | Purchase | 194 | (5 | ) | ||||||||||||
1/2/2004 | Purchase | 209 | (5 | ) | ||||||||||||
2/2/2004 | Purchase | 675 | (5 | ) | ||||||||||||
2/2/2004 | Purchase | 306 | (5 | ) | ||||||||||||
3/1/2004 | Purchase | 480 | (5 | ) | ||||||||||||
4/1/2004 | Purchase | 657 | (5 | ) | ||||||||||||
5/3/2004 | Purchase | 386 | (5 | ) | ||||||||||||
5/20/2004 | Purchase | 15,385 | (1 | ) | ||||||||||||
6/1/2004 | Purchase | 498 | (5 | ) | ||||||||||||
7/1/2004 | Purchase | 372 | (5 | ) | ||||||||||||
8/2/2004 | Purchase | 242 | (5 | ) | ||||||||||||
9/1/2004 | Purchase | 622 | (5 | ) | ||||||||||||
10/1/2004 | Purchase | 249 | (5 | ) | ||||||||||||
11/1/2004 | Purchase | 446 | (5 | ) | ||||||||||||
12/1/2004 | Purchase | 273 | (5 | ) | ||||||||||||
1/3/2005 | Purchase | 508 | (5 | ) | ||||||||||||
Ivan R. Sabel
|
3/11/2004 | Purchase | 2,750 | (6 | ) | |||||||||||
4/1/2004 | Purchase | 934 | (5 | ) | ||||||||||||
5/3/2004 | Purchase | 771 | (5 | ) | ||||||||||||
5/20/2004 | Purchase | 15,385 | (5 | ) | ||||||||||||
6/1/2004 | Purchase | 708 | (5 | ) | ||||||||||||
7/1/2004 | Purchase | 645 | (5 | ) | ||||||||||||
8/2/2004 | Purchase | 376 | (5 | ) | ||||||||||||
9/1/2004 | Purchase | 1,335 | (5 | ) | ||||||||||||
10/1/2004 | Purchase | 387 | (5 | ) | ||||||||||||
11/1/2004 | Purchase | 796 | (5 | ) | ||||||||||||
12/1/2004 | Purchase | 319 | (5 | ) | ||||||||||||
1/3/2005 | Purchase | 924 | (5 | ) | ||||||||||||
2/1/2005 | Purchase | 685 | (5 | ) | ||||||||||||
3/1/2005 | Purchase | 659 | (5 | ) | ||||||||||||
Donald L. Seeley
|
6/2/2003 | Purchase | 11,000 | (6 | ) | |||||||||||
5/20/2004 | Purchase | 15,385 | (1 | ) | ||||||||||||
Marilyn R. Seymann, Ph.D.
|
6/2/2003 | Purchase | 11,000 | (6 | ) | |||||||||||
2/2/2004 | Purchase | 675 | (5 | ) | ||||||||||||
5/20/2004 | Purchase | 15,385 | (1 | ) | ||||||||||||
Richard D. Skelly, Jr.
|
3/5/2003 | Purchase | 750 | (8 | ) | |||||||||||
4/1/2003 | Purchase | 60,000 | (1 | ) | ||||||||||||
5/20/2004 | Purchase | 13,043 | (1 | ) | ||||||||||||
5/10/2004 | Sale | 6,690 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 8,878 | (1 | ) | ||||||||||||
Cindy H. Susienka
|
2/27/2003 | Purchase | 7,824 | (7 | ) | |||||||||||
3/3/2003 | Purchase | 3,000 | (8 | ) | ||||||||||||
3/3/2003 | Purchase | 2,000 | (8 | ) | ||||||||||||
4/1/2003 | Purchase | 60,000 | (1 | ) | ||||||||||||
5/20/2004 | Purchase | 49,358 | (1 | ) | ||||||||||||
2/27/2003 | Sale | 9,781 | (7 | ) |
I-6
Date of | Transaction Type | Number of | Nature of | |||||||||||||
Name | Transaction | (Purchase/Sale) | Shares | Transaction | ||||||||||||
5/10/2004 | Sale | 6,640 | (2 | ) | ||||||||||||
8/18/2004 | Sale | 1,266 | (2 | ) | ||||||||||||
3/10/2005 | Purchase | 32,245 | (1 | ) |
(1) | Restricted stock award. |
(2) | Shares surrendered in payment of taxes associated with scheduled vesting of restricted shares. |
(3) | Issuance of phantom stock units pursuant to the Executive Deferred Compensation Plan. |
(4) | Cancellation of unvested shares due to termination of the Executive Deferred Compensation Plan. |
(5) | Issuance of phantom stock units pursuant to the Non-Employee Director Deferred Compensation Plan. |
(6) | Non-qualified stock option grant. |
(7) | Distribution of vested shares of BEI common stock in connection with termination of Executive Deferred Compensation Plan. |
(8) | Open market purchase. |
I-7
(i) no BEI Participant is, or has been within the past year, a party to any contract, arrangement or understanding with any person with respect to any securities of BEI, including, but not limited to, joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies. | |
(ii) no BEI Participant beneficially owns, directly or indirectly, any securities of any subsidiary of BEI. | |
(iii) no associates of any BEI Participant beneficially own, directly or indirectly, any securities of BEI. | |
(iv) none of the BEI Participants or any of their respective associates, has had or will have a direct or indirect material interest in any transaction or series of similar transactions since the beginning of January 1, 2004, or any currently proposed transactions or series of similar transactions, to which BEI or any of its subsidiaries was or is to be a party in which the amount involved exceeds $60,000. | |
(v) none of the BEI Participants nor any of their respective associates has any arrangements or understandings with any person with respect to (i) any future employment by BEI or its affiliates or (ii) any future transactions to which BEI or any of its affiliates will or may be a party. | |
(vi) no BEI Participant has any substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be acted upon at the Annual Meeting. |
I-8
Name and Principal Business Address | Principal Occupation | |
Mark Shafir
|
Managing Director, Lehman Brothers | |
Brian McCarthy
|
Managing Director, Lehman Brothers | |
Barry Blake
|
Senior Vice President, Lehman Brothers | |
David Sturek
|
Vice President, Lehman Brothers | |
Robert Snead
|
Associate, Lehman Brothers | |
Doug Braunstein
|
Managing Director, JPMorgan | |
Brian Gottlieb
|
Managing Director, JPMorgan | |
Cory Rapkin
|
Vice President, JPMorgan | |
David McCollough
|
Vice President, JPMorgan | |
Patrick Cook
|
Vice President, JPMorgan | |
Aaron Rubin
|
Associate, JPMorgan |
II-1
(i) no Other BEI Participant is, or has been within the past year, a party to any contract, arrangement or understanding with any person with respect to any securities of BEI, including, but not limited to, joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies. | |
(ii) no Other BEI Participant beneficially owns, directly or indirectly, any securities of any subsidiary of BEI. | |
(iii) no associates of any Other BEI Participant beneficially own, directly or indirectly, any securities of BEI. | |
(iv) none of the Other BEI Participants or any of their respective associates, has had or will have a direct or indirect material interest in any transaction or series of similar transactions since the beginning of January 1, 2004, or any currently proposed transactions or series of similar transactions, to which BEI or any of its subsidiaries was or is to be a party in which the amount involved exceeds $60,000. | |
(v) none of the Other BEI Participants nor any of their respective associates has any arrangements or understandings with any person with respect to (i) any future employment by BEI or its affiliates or (ii) any future transactions to which BEI or any of its affiliates will or may be a party. | |
(vi) no Other BEI Participant has any substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be acted upon at the Annual Meeting. |
II-2
PROXY
BEVERLY ENTERPRISES, INC.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Douglas J. Babb, William R. Floyd and Jeffrey P. Freimark, and each of them, as proxies, each with the power to appoint his substitute, to represent and to vote as designated below, all the shares of common stock of Beverly Enterprises, Inc. held of record by the undersigned on March 7, 2005 at the Annual Meeting of Stockholders to be held on April 21, 2005 and any and all adjournments or postponements thereof.
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting and any and all adjournments or postponements thereof. This Proxy when properly executed will be voted in the manner directed herein by the undersigned. If no specification is made, the Proxy will be voted FOR the election of the directors named in the Proxy Statement; FOR the appointment of Ernst & Young LLP as independent auditors for 2005; and AGAINST the shareholder proposals listed as Items 3-5 on the reverse side of this proxy card.
The undersigned hereby revokes all proxies previously given by the undersigned to vote at the Annual Meeting of Stockholders or any adjournment or postponement thereof.
IMPORTANT THIS PROXY CARD MUST BE SIGNED AND DATED ON THE REVERSE SIDE.
SEE REVERSE SIDE |
þ
|
Please mark your votes as in this example |
Your board of directors recommends a vote FOR the approval of proposals 1 & 2
WITHHOLD | ||||||||
FOR | AUTHORITY | |||||||
all nominees | to vote for all nominees | |||||||
listed to left | listed to left | *EXCEPTIONS | ||||||
1. Election Of Directors | ||||||||
Nominees:
|
William R. Floyd, Melanie Creagan Dreher, Ph.D., John D. Fowler, Jr., John P. Howe, III, M.D., James W. McLane, Ivan R. Sabel, Donald L. Seeley and Marilyn R. Seymann, Ph.D. | o | o | o |
(INSTRUCTIONS: To withhold authority to vote for any individual nominee, mark the Exceptions box and write that nominees name in the space provided below.)
* Exceptions
|
||
If any nominee named above declines or is unable to serve as a director, the persons named as proxies, and each of them, shall have full discretion to vote for any other person who may be nominated.
FOR | AGAINST | ABSTAIN | ||||||
2.
|
Appointment of Ernst & Young LLP as Independent Auditors for 2005 | o | o | o |
your board of directors recommends a vote AGAINST proposals 3, 4 and 5.
FOR |
AGAINST |
ABSTAIN |
||||||
3.
|
Amend the By-Laws to fix the number of Directors constituting the entire Board at Eight | o | o | o | ||||
4.
|
Repeal any Amendment to the By-Laws adopted after May 29, 1997, other than the Amendment described in Proposal 3 | o | o | o | ||||
5.
|
Require that Proposals 3 and 4 be presented prior to the Election of Directors and before any other business is conducted at the Annual Meeting. | o | o | o |
To change your address, please mark this box. | o |
Date | , 2005 | |||||
Signature | ||||||
Signature/Title | ||||||
NOTE: | Please sign exactly as name appears on this proxy card. When shares are held by joint tenants, both should sign. When signing as attorney, as executor, administrator, trustee or guardian, please give full title as such. If a corporation, please sign in full corporate name by President or other authorized officer. If a partnership, please sign in partnership name by authorized person. |
PLEASE SIGN, DATE AND RETURN TODAY IN THE ENCLOSED ENVELOPE. THIS PROXY WILL NOT BE USED IF YOU ATTEND THE ANNUAL MEETING IN PERSON AND SO REQUEST.